CVS partners with Google Health to help customers manage Rx histories
WOONSOCKET, R.I. CVS Caremark has extended its partnership with Google Health to enable consumers to import their prescription histories into a Google Health Personal Health Record.
Through the expanded partnership, consumers who use the company’s pharmacy benefit management services to store, organize and manage their prescription history information online can link their Caremark.com account to Google Health to import their prescription history. Access to this information can further facilitate and enhance communications between consumers and their health care providers.
“We are excited to be able to provide our PBM clients and their customers with the ability to securely import their individual prescription histories into a Google Health PHR,” Jon Roberts, senior vice president and chief information officer at CVS Caremark said. “Our partnership with Google Health underscores our commitment to facilitating greater consumer engagement in health care and enables us to provide our clients and customers with innovative health and pharmacy services that are safe, affordable and easy to access.”
All of CVS Caremark’s PBM clients have the opportunity to make this connectivity with Google Health available to their plan participants. In order to maintain patient privacy, the consumer making the request for information will need to be authenticated on the Caremark.com Web site before any data is shared with Google Health.
CVS Caremark has been involved with Google Health since it was launched in May 2008. At the time of launch, those patients who received treatment at MinuteClinic locations in Knoxville and Chattanooga, Tenn., were able to import their visit summaries into their Google Health accounts.
Medimetriks announces agreement to market treatments for impetigo
FAIRFIELD, N.J. Medimetriks Pharmaceuticals has entered into a licensing agreement with Perrigo for U.S. Marketing rights to Centany Ointment and two prescription keratolytic brands, Medimetriks announced Tuesday.
Johnson & Johnson’s OrthoNeutrogena professional division previously marketed Centany, which is used for treating impetigo caused by Straphylococcus aureas and Streptococcus pyogenes bacteria. The Food and Drug Administration approved it in 2002.
The two keratolytic brands are urea-based therapies for treating severe dry skin.
“We are happy to have a partner that brings such a record of success in the branded pharmaceutical business,” Perrigo executive vice president Sharon Kochan said in a statement. “We believe the licensed products are in good hands, given Medimetriks management’s proven abilities in building a successful business in the dermatology and podiatry markets.”
Few healthcare providers receive adequate training, tools to help patients quit smoking
NEW YORK A new study suggests that few healthcare workers have sufficient training in smoking cessation to help patients quit.
The study, presented Monday at the annual meeting of the American College of Chest Physicians in Philadelphia, found that 87 to 93 percent of healthcare providers receive less than five hours of smoking cessation training, while less than 6 percent know the governmental Agency for Healthcare Research and Quality’s guidelines for treating people with tobacco dependence.
The study surveyed 600 people working in health care, including physicians, nurse practitioners, pharmacists, social workers and students, and divided them into prescribers and non-prescribers.